Grifols (ES:GRF) has released an update.
Grifols, S.A., a leading healthcare company, has successfully completed the sale of a 20% stake in SRAAS to the Haier Group, securing 12.5 billion RMB (EUR 1.6 trillion net). The proceeds from this significant transaction have been promptly deposited in the company’s Spanish bank accounts.
For further insights into ES:GRF stock, check out TipRanks’ Stock Analysis page.
